Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | NRAS |
| Variant | Y64D |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | NRAS Y64D does not lie within any known functional domains of the Nras protein (UniProt.org). Y64D does not promote tumor formation in animal models in a pooled screening assay and induces a gene expression profile less correlated with activating NRAS variants in culture (PMID: 27147599), and based on the effects of HRAS Y64D, which results in a loss of Hras GTPase activity in in vitro assays and failure to transform cells in culture (PMID: 1730690), is predicted to lead to a loss of Nras protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
NRAS mutant NRAS exon3 NRAS Y64D NRAS mutant NRAS inact mut NRAS Y64D |
| Transcript | NM_002524.5 |
| gDNA | chr1:g.114713900A>C |
| cDNA | c.190T>G |
| Protein | p.Y64D |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002524 | chr1:g.114713900A>C | c.190T>G | p.Y64D | RefSeq | GRCh38/hg38 |
| NM_002524.4 | chr1:g.114713900A>C | c.190T>G | p.Y64D | RefSeq | GRCh38/hg38 |
| NM_002524.5 | chr1:g.114713900A>C | c.190T>G | p.Y64D | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|